Literature DB >> 17201238

Factors associated with acute health care use in a national adult asthma management program.

Tze-Pin Ng1, Tow-Keang Lim, John Abisheganaden, Philip Eng, Fai-Lam Sin.   

Abstract

BACKGROUND: The use of acute health care resources for asthma is considerable. Disease severity is an established risk factor, but ethnicity and health care factors are less well studied.
OBJECTIVE: To investigate the independent associations of ethnicity and health care factors with acute resource use for asthma.
METHODS: Longitudinal data from a national adult asthma management program providing universal access to care were analyzed. Outcome measures were unscheduled physician visits with urgent nebulization, emergency department (ED) visits, and hospitalizations.
RESULTS: In multivariate analyses, markers of disease severity were found to be significantly associated with all acute resource use. After controlling for disease severity, ethnicity was associated with increased risk of all acute resource use; Indian (vs Chinese) ethnicity was associated with increased risk of unscheduled physician visits (hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.03-1.70), ED visits (HR, 1.61; 95% CI, 1.12-2.32), and hospitalizations (HR, 1.49; 95% CI, 1.03-2.16). Malay ethnicity was associated with unscheduled physician visits (HR, 1.30; 95% CI, 1.01-1.68) and ED visits (HR, 1.55; 95% CI, 1.09-2.19). Default of follow-up appointments was associated with unscheduled physician visits (HR, 1.47; 95% CI, 1.08-2.00), ED visits (HR, 2.35; 95% CI, 1.59-3.45), and hospitalizations (HR, 1.74; 95% CI, 1.09-2.76). Poor inhaler technique was associated with ED visits (HR, 1.86; 95% CI, 1.05-3.30) and smoking with unscheduled physician visits (HR, 1.38; 95% CI, 1.09-1.76).
CONCLUSIONS: In addition to markers of asthma severity, ethnicity, smoking, discontinuity of care, and self-care behavior are risk factors for acute resource utilization and represent target groups and elements of asthma intervention for improving asthma outcomes.

Mesh:

Year:  2006        PMID: 17201238     DOI: 10.1016/S1081-1206(10)60970-2

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

1.  Optimal cut-off value and clinical usefulness of the Adherence Starts with Knowledge-12 in patients with asthma taking inhaled corticosteroids.

Authors:  Masaya Takemura; Masayuki Nishio; Kensuke Fukumitsu; Norihisa Takeda; Hiroya Ichikawa; Takamitsu Asano; Hiroki Tomita; Yoshihiro Kanemitsu; Kosho Yoshikawa; Akio Niimi
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Role of community pharmacists in asthma - Australian research highlighting pathways for future primary care models.

Authors:  B Saini; I Krass; L Smith; S Bosnic-Anticevich; C Armour
Journal:  Australas Med J       Date:  2011-04-30

3.  Followup after an emergency department visit for asthma: urban/rural patterns.

Authors:  Kelley Withy; James Davis
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

4.  Ten-year longitudinal study of factors influencing nocturnal asthma symptoms among Asian patients in primary care.

Authors:  Ngiap Chuan Tan; Nivedita V Nadkarni; Weng Kit Lye; Usha Sankari; van Hai Nguyen
Journal:  NPJ Prim Care Respir Med       Date:  2015-10-29       Impact factor: 2.871

Review 5.  Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype.

Authors:  R H Dougherty; J V Fahy
Journal:  Clin Exp Allergy       Date:  2009-02       Impact factor: 5.018

Review 6.  Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden.

Authors:  Achim Beule
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

7.  Improving asthma care with Asthma-COPD Afterhours Respiratory Nurse at Emergency (A-CARE).

Authors:  Si Yuan Chew; Jenneth Yue Ling Leow; Adrian Kok Wai Chan; Jing Jing Chan; Kenneth Boon Kiat Tan; Butta Aman; Donna Tan; Mariko Siyue Koh
Journal:  BMJ Open Qual       Date:  2020-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.